Tevogen Bio Inc. (TVGN)
NASDAQ: TVGN
· Real-Time Price · USD
0.67
-0.11 (-14.04%)
At close: Oct 03, 2025, 3:59 PM
0.65
-3.50%
Pre-market: Oct 06, 2025, 05:28 AM EDT
Tevogen Bio Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
Net Income | -5.5M | -10.37M | -9.44M | -5.91M | -9.66M | 10.51M | -828.92K | -3.9M | -22.18M | -30.76M | 2.61M | 1.61M | 207K | -25.99K | -17.33K |
Depreciation & Amortization | 26.59K | 105.4K | 103.55K | 101.74K | -17.2K | 98.3K | 259.15K | 198.02K | -11.74K | 91.21K | 196.06K | 2.1K | n/a | n/a | n/a |
Stock-Based Compensation | 3.24M | 7.29M | 7.96M | 3.33M | 3.14M | 26.33M | n/a | n/a | n/a | n/a | 720.82K | 1.26M | n/a | n/a | n/a |
Other Working Capital | -788.23K | 185.67K | 1.35M | -320.71K | -80.03K | -1.18M | -187.57K | 91.39K | -80.54K | 142.39K | 160.25K | 83.82K | 242.31K | 80.22K | -571.78K |
Other Non-Cash Items | 261.02K | 10.72K | -2.38M | -176.09K | 3.64M | -40.38M | 40.05K | 1.48M | 20.1M | 28.43M | -2.87M | -1.88M | -435.96K | -346.52K | -201.61K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.21M | -349.82K | 710.77K | -1.15M | -80.03K | 517.84K | -46.2K | 431.38K | -125.87K | 55.8K | 198.93K | 156.23K | 212.69K | 169.84K | -533.33K |
Operating Cash Flow | -3.19M | -3.31M | -3.05M | -3.8M | -2.98M | -2.16M | -693.71K | -1.8M | -2.22M | -2.18M | -13.86K | -42.6K | -45.9K | -113.03K | -713.83K |
Capital Expenditures | 3.00 | 3.00 | -4 | n/a | n/a | n/a | n/a | n/a | n/a | -133K | -165.39K | -126.64K | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | -67.5K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -351.9M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | 9.71M | n/a | n/a | 333.27M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | 9.65M | n/a | n/a | -133K | -165.39K | -126.64K | n/a | n/a | -351.9M |
Debt Repayment | 1.4M | 2M | n/a | 1M | n/a | n/a | 350K | 1.15M | 901K | 2.5M | 2.5M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | -9.71M | -333.27M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 500K | n/a | 11M | n/a | 2.8M | 229.33K | 72.5K | -200K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 1.9M | 4M | 2M | 5M | 2.8M | 2.43M | -9.29M | 950K | 901K | 2.5M | 2.5M | n/a | n/a | n/a | 352.96M |
Net Cash Flow | -1.29M | 691.94K | -1.05M | 1.2M | -182.51K | 265.5K | -338.71K | -849.99K | -2.22M | 189.87K | -13.86K | -42.6K | -45.9K | -113.03K | 344.58K |
Free Cash Flow | -3.19M | -3.31M | -3.05M | -3.8M | -2.98M | -2.16M | -693.71K | -1.8M | -2.22M | -2.31M | -179.25K | -169.24K | -45.9K | -113.03K | -713.83K |